Mogo Reports Results for Q1 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ('Mogo' or the 'Company'), a digital wealth and payments business, today announced its financial and operational results for the first quarter ended March 31, 2025.
'Our Q1 results were highlighted by continued strong double-digit growth from our Wealth and Payments businesses – the two main growth priorities for Mogo,' said Greg Feller, Mogo's Chief Financial Officer. 'Given our current scale in these markets, and the massive opportunity for disruption through innovation, we are making disciplined investments in these businesses while maintaining positive Adjusted EBITDA. This is about scaling intelligently and with agility as we build for long-term growth, underpinned our new AI-native platform strategy. We increased our cash position from year end, and expect additional monetizations this year to further strengthen our balance sheet.'
'This quarter we launched MOGO 3.0, our internal initiative to become a fully AI-native company,' said David Feller, Mogo's Founder and CEO. 'That means consolidating our platforms, automating core workflows, and embedding AI across wealth, lending, and operations. We've already begun executing on this transformation, and we believe it sets the foundation for stronger margins, faster product development, and smarter customer experiences going forward.'
Key Financial Highlights for Q1 2025
Subscription & Services revenue of $10.7 million in Q1 2025 included:
Wealth Revenue growth of 41% from Q1 2024 to $3.5 million
Payments Revenue growth of 34% from Q1 2024 to $2.6 million
Total revenue of $17.3 million in Q1 2025, a 3% decrease over the prior year, reflecting the company's exit of the low margin legacy institutional brokerage.
Adjusted revenue 2 growth of 2% from Q1 2024 to $16.7 million.
Gross profit was $11.6 million in Q1 2025, consistent with Q1 2024. Gross margin was 67.0% in Q1 2025 versus 64.5% in Q1 2024.
Adjusted EBITDA 2 of $1.1 million in Q1 2025 (6.1% margin), compared with $1.0 million (5.8% margin) in Q1 2024.
Cash flow from operating activities before investment in gross loans receivable was positive for the 10 th consecutive quarter, reaching $3.8 million in Q1 2025, up 108% versus Q1 2024.
Total Cash flow from operating activities was positive for the fourth consecutive quarter at $0.6 million in Q1 2025.
Adjusted net loss 2 of $1.5 million compared with adjusted net loss of $1.6 million in Q1 2024.
Net loss of $11.9 million in Q1 2025, compared with net loss of $3.6 million in Q1 2024. Net loss in the current quarter includes an $8.3 million non-operating revaluation loss on marketable securities reflecting significant financial market volatility in the period.
Cash, Marketable Securities & Investments totaled $38.8 million as of March 31, 2025.
Cash and restricted cash was $13.0 million, up from $11.0 million at year-end.
Marketable securities of $16.3 million
Investment portfolio of $9.5 million
Monetized $1.7 million of marketable securities and $0.7 million of its investment portfolio.
Renewed and lowered rate on credit facility – In February 2025, Mogo amended its senior secured credit facility with funds managed by affiliates of Fortress Investment Group LLC. The amended facility extends the maturity date by three years, until January 2, 2029, and reduces the interest rate by 100 basis points from 8% plus SOFR, to 7% plus SOFR.
Business & Operations Highlights
Mogo members increased to 2.22 million at quarter end, up 5% from Q1 2024.
Continued growth in payments volume – Mogo's digital payment solutions business, Carta Worldwide, processed $3.2 billion of payment volume in Q1 2025, an increase of 26% compared to Q1 2024.
Growth in wealth assets under management – Assets under management in the Company's wealth businesses increased 8% year-over-year to $436 million.
Enhancements to wealth offerings – During the quarter, Mogo continued its strong product improvement to its wealth offerings, including:
Continued to scale our AI-native customer support capabilities, resulting in an approximate 100% increase in customer inquiries resolved autonomously through email and chat
Expanded our AI-powered investing mastery feature, launching interactive quizzes and original content to help members deepen their understanding of intelligent investing strategies.
Exited legacy brokerage business – In February 2025, Mogo exited its institutional brokerage business, as part of management's strategic focus on eliminating sub-scale revenue streams and prioritizing higher margin offerings. The institutional brokerage business contributed $5.3 million of revenue for the year ended December 31, 2024, with a negligible operating margin. These revenues are reported within other subscription and services revenue.
Carta OCI migration – Mogo's payments subsidiary, Carta, completed its transition to Oracle Cloud Infrastructure ('OCI'), better positioning the business to scale and achieve its vision to become one of the leading low-cost payments platforms in Europe.
Financial Outlook
The outlook that follows made by Mogo, constitutes forward-looking information within the meaning of applicable securities laws, and is based on a number of assumptions and subject to a number of risks. Actual results could vary materially as a result of numerous factors, including certain risk factors, many of which are beyond Mogo's control. Please see "Forward-looking Statements" below for more information.
Mogo reiterated its financial guidance for fiscal 2025 as outlined with its year-end financial results. Key elements of this include the following:
When adjusting for the previously disclosed exit of the brokerage business, the Company expects subscription & services revenue to grow at a mid-to-high single-digit rate.
The Company expects revenue from wealth to increase by 20-25% in 2025, and its payments business is projected to grow in the mid- to-high teens percentages.
Interest revenue from the Company's lending business is expected to decrease by approximately 8-10% in 2025, driven by a more cautious approach to lending due to economic uncertainty.
Adjusted EBITDA 3 is expected to be in the range of $5 to $6 million.
1 Includes cash, restricted cash and cash equivalents.
2 Non-IFRS measure. For more information regarding our use of these non-IFRS measures and, where applicable, a reconciliation to the most comparable IFRS measure, see 'Non-IFRS Financial Measures' in the Company's MD&A for the period ended March 31, 2025.
3 Adjusted EBITDA, adjusted revenue and adjusted net income (loss) are non-IFRS measures. Management has not reconciled these forward-looking non-IFRS measures to their most directly comparable IFRS measure, net loss before tax. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain IFRS components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable IFRS measures.
Conference Call & Webcast
Mogo will host a conference call to discuss its Q1 2025 financial results at 3:00 p.m. ET on May 8, 2025. The call will be hosted by David Feller, Founder and CEO, and Greg Feller, President and CFO. To participate in the call, dial (289) 514-5100 or (800) 717-1738 (International) using conference ID: 77526. The webcast can be accessed at http://investors.mogo.ca. Listeners should access the webcast or call 10-15 minutes before the start time to ensure they are connected.
Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS financial measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. These measures are provided as additional information to complement the IFRS financial measures contained herein by providing further metrics to understand the Company's results of operations from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. We use non-IFRS financial measures, including Adjusted EBITDA, Adjusted net loss and Cash provided by (used in) operating activities before investment in gross loans receivable, to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. Our management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements. For more information, please see 'Non-IFRS Financial Measures' in our Management's Discussion and Analysis for the period ended March 31, 2025, which is available at www.sedarplus.com and at www.sec.gov.
The following tables present a reconciliation of each non-IFRS financial measure to the most comparable IFRS financial measure.
Adjusted EBITDA
($000s)
Three months ended
March 31,
2025
March 31,
2024
Net loss before tax
$(11,970)
$(3,695)
Credit facility interest expense
1,446
1,656
Debenture and other financing expense
913
806
Accretion related to debentures
154
178
Stock-based compensation
475
561
Depreciation and amortization
1,954
2,376
Revaluation loss (gain)
7,662
(1,088)
Other non-operating expense
416
254
Adjusted EBITDA
1,050
1,048
Expand
Adjusted Net Loss
($000s)
Three months ended
March 31,
2025
March 31,
2024
Net loss before tax
$(11,970)
$(3,695)
Stock-based compensation
475
561
Depreciation and amortization
1,954
2,376
Revaluation loss (gain)
7,662
(1,088)
Other non-operating expense
416
254
Adjusted net loss
(1,463)
(1,592)
Expand
Cash Provided by (used in) Operations before Investment in Gross Loans Receivable
Forward-Looking Statements
This news release contains 'forward-looking statements' within the meaning of applicable securities legislation, including statements regarding the Company's initiative to become a fully AI-native company and financial outlook for 2025. Forward-looking statements are typically identified by words such as "may", "will", "could", "would", "anticipate", "believe", "expect", "intend", "potential", "estimate", "budget", "scheduled", "plans", "planned", "forecasts", "goals" and similar expressions. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo's growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, many of which are outside of Mogo's control, including the receipt of any required regulatory approval. For a description of the risks associated with Mogo's business please refer to the 'Risk Factors' section of Mogo's current annual information form, which is available at www.sedarplus.com and www.sec.gov. Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
About Mogo
Mogo Inc. (NASDAQ:MOGO; TSX:MOGO) is a financial technology company with three distinct business lines: wealth, lending, and payments. Our mission is to provide consumers with innovative financial solutions that drive long-term financial health and success. We operate with a differentiated approach in each business, leveraging technology, behavioral science, and financial tools to create unique value propositions in our respective markets.
Our wealth and lending businesses are focused on the Canadian market, where we are the only subprime consumer lender that also offers a holistic wealth and investing solution. This unique integration is designed to help consumers transition from borrowing and debt to long-term wealth building. Separately, our payments business is operated through Carta Worldwide, a wholly owned subsidiary that provides modern card issuing and processing solutions, primarily in Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
STATEN ISLAND, N.Y., June 17, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it has entered into a warrant inducement agreement (the "Letter Agreement") with a certain holder ("Holder") of existing warrants to purchase up to an aggregate of 4,445,435 shares of common stock (the "Existing Warrants") having exercise prices ranging from $3.25 to $3.26 per share, issued by the Company in July 2022 and May 2023, wherein the Holder agreed to exercise the Existing Warrants at a reduced exercise price of $0.675 per share, resulting in gross proceeds of approximately $2.67 million, before deducting offering fees and other expenses payable by the Company. In consideration for the exercise of the Existing Warrants for cash, the investors received 6,223,609 G-1 warrants (the "G-1 Warrants") and 2,667,261 G-2 warrants (the "G-2 Warrants) to purchase up to an aggregate of 8,890,870 shares of common stock (the "New Warrants"). The G-1 Warrants are exercisable immediately at an exercise price of $0.425 per common share and will expire five years from the issuance date. The G-2 Warrants are exercisable upon shareholder approval at an exercise price of $0.425 per common share and will expire five years from the issuance date. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective resale registration statements on Form S-1 (File Nos. 333-267412 and 333-273015). The transaction is expected to close no later than June 20, 2025, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the exercise for working capital and general corporate purposes. The New Warrants are being issued in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and Regulation D promulgated thereunder and, along with the shares of common stock underlying such New Warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the New Warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Ibezapolstat Ibezapolstat is the Company's lead antibiotic candidate advancing to international Phase 3 clinical trials to treat patients with C. difficile Infection (CDI). Ibezapolstat is a novel, orally administered antibiotic being developed as a Gram-Positive Selective Spectrum (GPSS®) antibacterial. It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections. Ibezapolstat's unique spectrum of activity, which includes C. difficile but spares other Firmicutes and the important Actinobacteria phyla, appears to contribute to the maintenance of a healthy gut microbiome. In June 2018, ibezapolstat was designated by the U.S. Food and Drug Administration (FDA) as a Qualified Infectious Disease Product (QIDP) for the treatment of patients with CDI and will be eligible to benefit from the incentives for the development of new antibiotics established under the Generating New Antibiotic Incentives Now (GAIN) Act. In January 2019, FDA granted "Fast Track" designation to ibezapolstat for the treatment of patients with CDI. The CDC has designated C. difficile as an urgent threat highlighting the need for new antibiotics to treat CDI. About Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillinresistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit Forward-Looking Statements Any statements in this press release about our future expectations, plans and prospects, including statements regarding our strategy, future operations, prospects, plans and objectives, the timing and completion of the offering; the satisfaction of customary closing conditions related to the offering and the intended use of proceeds therefrom, and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: whether ibezapolstat will benefit from the QIDP designation; whether ibezapolstat will advance through the clinical trial process on a timely basis; whether the results of the clinical trials of ibezapolstat will warrant the submission of applications for marketing approval, and if so, whether ibezapolstat will receive approval from the FDA or equivalent foreign regulatory agencies where approval is sought; whether, if ibezapolstat obtains approval, it will be successfully distributed and marketed; and other risks and uncertainties described in the Company's annual report filed with the Securities and Exchange Commission on Form 10-K for the year ended December 31, 2024, and in the Company's subsequent filings with the Securities and Exchange Commission. Such forward- looking statements speak only as of the date of this press release, and Acurx disclaims any intent or obligation to update these forward-looking statements to reflect events or circumstances after the date of such statements, except as may be required by law. Investor Contact: Acurx Pharmaceuticals, Inc. David P. Luci, President & Chief Executive Officer Tel: 917-533-1469 Email: davidluci@ View original content: SOURCE Acurx Pharmaceuticals, Inc. Sign in to access your portfolio
Yahoo
40 minutes ago
- Yahoo
Best Stock to Buy Right Now: Shopify vs Lightspeed?
Written by Brian Paradza, CFA at The Motley Fool Canada Canadian tech investors hunting for growth in June may find themselves weighing two prominent TSX stocks: the e-commerce giant Shopify (TSX:SHOP) and the beaten-down retail software specialist Lightspeed Commerce (TSX:LSPD). Both had their struggles, one has recovered substantially, and they offer distinct paths to potential returns. However, their risk profiles and current trajectories couldn't be more different. Let's break down which growth stock might be the better fit for your portfolio today. Shopify isn't just an online store builder anymore; it has evolved into a global commerce operating system. Its latest quarterly results (Q1 2025) reinforced its strength: revenue surged 27% year-over-year to US$2.4 billion, gross merchandise volume (GMV) grew 23%, and its free cash flow margin hit a healthy 15%. Crucially, its Payments platform now operates in 39 countries after a massive expansion, achieving 64% penetration of its GMV. Shopify's key advantage is its proven resilience and profitability. It generates significant, self-sustaining cash flow. Operating margins expanded to 14.8% over the past 12 months, up dramatically from 3.7% in 2023. Management emphasizes agility – reacting swiftly to challenges like new tariffs by rolling out features like localized buying filters and artificial intelligence (AI) powered duty calculators (' in days or weeks. This execution speed, combined with a diverse merchant base spanning tiny startups to well-established retail giants, provides stability. However, quality comes at a price. Shopify stock trades at a forward price-to-earnings (P/E) ratio near 75 and a forward enterprise-value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) multiple of 67.3. You are paying handsomely for this premium growth and stability. While Shopify's growth rate is impressive (targeting mid-20% revenue growth for the second quarter), the large-cap stock's growth rate is naturally slowing from its hyper-growth past. Trade conflicts and economic slowdowns remain potential headwinds. Lightspeed presents a stark contrast. Once a high-flyer, its stock sits at a painful 90% below its all-time highs. Investor sentiment remains low following past missteps and a major restructuring. Yet, here lies the potential opportunity. The company is showing signs of a possible turnaround. Revenue growth, while slower than Shopify's, remains respectable at around 18% recently. Management is aggressively repurchasing shares, buying back over 12% of the outstanding stock in the past year at depressed prices – a strong signal it believes the stock is undervalued. Gross margins are expanding due to tighter cost controls and existing customers adopting more modules (increasing average revenue per user). Crucially, Lightspeed is inching towards free-cash-flow break-even and sustained profitability within the next one to two years. Valuation is Lightspeed Commerce stock's compelling argument. Its forward P/E sits at a much cheaper 19.7, and its forward EV/EBITDA is 14.1 – far below Shopify's multiples. If Lightspeed successfully executes its restructuring, demonstrates clear sustainable profits, and rebuilds investor confidence, the stock could see a dramatic re-rating upwards. Triple-digit percentage gains aren't out of the question for patient investors if everything clicks. The catch? Significant execution risk remains. The market is still in 'wait-and-see' mode. Lightspeed needs to consistently hit its targets, prove its restaurant and retail segments are solidly growing post-restructuring, and overcome the stigma attached to its name. It currently lacks Shopify's current cash flow safety net. So, which is the better TSX tech stock to buy now? The answer hinges entirely on one's risk tolerance and investment horizon. Choose Shopify stock if you prioritize stability, proven profitability, strong cash flow, and market leadership, and you're comfortable paying a premium valuation for a company with a clear path to solid and profitable growth. Shopify is the 'sleep-easy' growth stock for the long haul. Otherwise, consider Lightspeed Commerce stock if you have a higher risk tolerance and seek deep value with explosive upside potential, and you believe management can deliver on profitability promises, reignite growth, and win back the market's favour. Looking ahead, Shopify stock may offer a smoother ride on a well-paved highway. Lightspeed offers a potentially thrilling, but much bumpier, path through uncharted territory. For most investors seeking reliable growth in the Canadian tech sector today, Shopify's combination of execution, profitability, and resilience makes it the stronger, albeit pricier, choice. Lightspeed is a fascinating speculative bet for those willing to embrace its higher risk in hopes of a spectacular rebound. Carefully weigh where you fall on that spectrum before hitting the buy button. The post Best Stock to Buy Right Now: Shopify vs Lightspeed? appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Shopify. The Motley Fool recommends Lightspeed Commerce. The Motley Fool has a disclosure policy. 2025
Business Wire
an hour ago
- Business Wire
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%
TOKYO--(BUSINESS WIRE)--Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 2030 1 on an area basis. [Features] Facilitates the efficient manufacture, or imposition, of high function optical film for 65 inch large screen displays. Designed to facilitate in-line multi-layer coating, for the needs of high-end TV models, which enable to reduce reflected light and improve visibility compared to single-layer products. By introducing new technologies that reduce power consumption and innovating production processes, the introduction of the new line is expected to reduce annual CO₂ emissions by approximately 30% compared to devices in current use. [Looking Ahead] DNP will expand its supply of high functional optical film to polarizer manufacturers in China, along with other countries and regions, aiming for annual sales of approximately 110 billion yen in FY 2026. 1: Source: Display Long-Term Demand Forecast Tracker – 1Q25, Omdia. More Details About DNP DNP was established in 1876, and has become a leading global company that leverages print-based solutions to engineer fresh business opportunities while protecting the environment and creating a more vibrant world for all. We capitalize on core competencies in microfabrication and precision coating technology to provide products for the display, electronic device, and optical film markets. We have also developed new products, such as vapor chamber and reflect array that offer next-generation communication solutions for more people-friendly information society.
